Resource: Therapeutic Education Programs (Cancer Institute Strasbourg Europe)

From Beacon
Revision as of 11:32, 6 December 2025 by Lucas (talk | contribs) (Update categories.)

forpatients francecountry Go back to Cancer Institute Strasbourg Europe page

Primary purpose: It offers group workshops and individual consultations with various healthcare experts, all aimed at empowering patients to take control of their treatment, address potential side effects, and foster better adherence to their prescribed therapies. It also addresses treated patients to help them return to their daily lives. There are two types of programs available: "Après cancer du sein", aimed at people who finished breast cancer treatment, and "Thérapie orale", aimed at patients under oral anti-cancer drugs.

Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.

Access to information: Click here to access. The programs "Après cancer du sein" and "Thérapie orale" are presented on page 58 of the report or page 30 of the pdf.

Mouth Throat Oropharynx Nasopharynx Hypopharynx Larynx Salivary glands Lips Tonsils base of tongue Voice box Esophagus Stomach Small intestine Large intestine Colon Rectum Anus Liver Gallbladder Bile ducts Pancreas Lung Trachea Bronchi Pleura Mediastinum Bone Cartilage Osteosarcoma Ewings sarcoma Skin Melanoma Scalp Lips Hands Feet Muscle Fat Tendon Ligament Blood vessels Connective tissue Sarcoma Angiosarcoma Liposarcoma Lobular Breast Nipple Areola Ductal Vulva Vagina Cervix Uterus Ovary Fallopian tubes Endometrium Prostate Testicles Penis Kidney Ureter Bladder Urethra Eye Brain Spinal cord Thyroid gland Parathyroid Adrenal glands Pituitary gland Pancreas Thymus gland Peritoneum Pericardium Retroperitoneum Mesothelium Blood Bone marrow Lymph nodes Spleen Leukemia hasCancerType::C00-D48: All neoplasms isPatientResource hasCancerType::C00-C97: All cancer types hasCancerType::C00-C14: Mouth/throat cancers hasCancerType::C15-C26: Digestive system cancers hasCancerType::C30-C39: Lung/chest cancers hasCancerType::C40-C41: Bone cancers hasCancerType::C43-C44: Skin cancers/melanoma hasCancerType::C45-C49: Soft tissue cancer hasCancerType::C50: Breast cancer hasCancerType::C51-C58: Female genitalia cancers hasCancerType::C60-C63: Male genitalia cancer hasCancerType::C64-C68: Urinary system cancers hasCancerType::C69-C72: Eye and brain cancer hasCancerType::C73-C75: Thyroid and other gland cancers hasCancerType::C76-C80: Cancers of unknown or unspecified areas hasCancerType::C81-C96: Cancers of the blood and immune system hasCancerType::C97-C97: Cancers in multiple locations from the start hasCancerType::D00-D09: Early-stage cancers not yet spread hasCancerType::D10-D36: Benign tumour hasCancerType::D37-D48: Growths of uncertain nature hasCancerType::unknown